Biologic drugs are a newer treatment option for chronic rhinosinusitis with nasal polyps. They work differently from other treatments. Nasal polyps are small, noncancerous growths that develop in the ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

SAN DIEGO -- Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed. Twice-yearly injections cut total nasal polyps score by ...

Most people with a condition known as chronic rhinosinusitis with nasal polyps (CRSwNP) are able to control their symptoms by using medicines that are sprayed into the nose or taken by mouth. But some ...

Nasal polyps are soft growths that can develop in your nose as a result of long-term swelling — from colds, allergies, and other conditions — in your nasal passages. They are more common in people who ...

SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...

Dupixent (dupilumab) is a prescription drug. It’s used to treat chronic (ongoing) rhinosinusitis (nasal and sinus inflammation) due to nasal polyps. Dupixent is a biologic drug and does not come in a ...

On Monday, GSK plc (NYSE:GSK) released headline results from the phase 3 trials ANCHOR-1 and ANCHOR-2, which assessed the efficacy and safety of depemokimab versus placebo in adults with chronic ...

Tezepelumab reduced the size of nasal polyps and the severity of nasal congestion in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, in a placebo-controlled study.

If you have nasal polyps, you likely deal with a range of symptoms, including nasal congestion, loss of smell and taste, and facial pain and pressure. To treat those symptoms, your doctor may have ...

Females have a higher odds of chronic rhinosinusitis without nasal polyps than men, according to a recent study.